Abstract:The gene editing technology enables cutting or/and inserting the target gene precisely. The CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9) system relies on two major elements, a guide RNA (gRNA) that recognizes a specific DNA sequence, and a nuclease Cas9 that cuts the target DNA and creates double-strand breaks (DSBs). Among a few gene-editing technologies available, CRISPR/Cas9 system has showed tremendous advantages over the others, mainly due to high efficiency of Cas9 and simple design of gRNA. As a versatile and powerful tool for genome engineering, the CRISPR/Cas9 technology has been used to generate genetically modified mice with unprecedented simplicity and speed, simply by timed delivery of Cas9/gRNA ribonucleoproteins (RNPs) into pronuclear-stage zygotes. The modified protocol introduces Cas9 protein instead of Cas9 mRNA by rapid electroporation, which enables the gene editing occurring before the first replication of the mouse genome, thus generating non-mosaic mutant embryos. Furthermore, it could be used to produce multiple gene mutations in a single mouse by co-delivering several gRNAs targeted to different genes. Herein, we summarize current applications of CRISPR/Cas9 technology in the field of neuroscience, and aim to provide concise information and perspectives for better utilizing this technology. In brain research, the CRISPR/Cas9 system can be applied either at the one-cell stage of the fertilized eggs in the form of Cas9/gRNA ribonucleoproteins, or at the stage of embryos or adults in the form of plasmid DNA or the viral vectors (commonly AAV variants) respectively. To deliver the system specifically into the developmental or adult brain, in utero electroporation, or stereotaxic injection is commonly employed. Several reports show that AAV-assisted Cas9/gRNA system could achieve a satisfied efficiency for genome editing in the adult mouse brain, but results vary depending on Cas9 activity, gRNA design, detection methods, and the condition of endogenous DNA repair mechanisms. Remarkable efforts have also been made to enhance the incidence of homology-directed repair for precise gene modifications. Regarding therapeutic genome editing, a couple of recent in vivo studies demonstrate that CRISPR/Cas9 system could contract or remove disease-causing alleles in animal models of certain hereditary diseases such as retinitis pigmentosa and Huntington′s disease, raising hope for translating therapeutic genome editing to clinical patients. In addition, we discuss major challenges and critical improvements for this technology, including a few modifications for promoting precise editing in non-dividing cells in the case of adult brain. In the future, application of CRISPR/Cas9 technology would be enhanced greatly in neuroscience by developing cell type-specific, timed delivery system in vivo and by combining with other powerful techniques for dissecting brain neural circuits in health and disease.

Dead Cas(t) light on new life: CRISPRa-mediated reprogramming of somatic cells into neurons.

An Improved CRISPR/dCas9 Interference Tool for Neuronal Gene Suppression

Strategy for Applying CRISPR/Cas9 Gene Editing Technology in Neuroscience

Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation

Direct Lineage Reprogramming to Neural Cells

A Cre-Dependent CRISPR/dCas9 System for Gene Expression Regulation in Neurons

Synthetic far-red light-mediated CRISPR-dCas9 device for inducing functional neuronal differentiation

CRISPR Activation Screens Systematically Identify Factors that Drive Neuronal Fate and Reprogramming

Development and application of CRISPR/Cas9 technologies in genomic editing.

Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Direct Conversion of Somatic Cells into Induced Neurons

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

A Neuron-Optimized CRISPR/dCas9 Activation System for Robust and Specific Gene Regulation

MicroRNA-Mediated Reprogramming of Somatic Cells into Neural Stem Cells or Neurons

CRISPR/Cas9 Genome Editing: A Promising Tool For Therapeutic Applications of Induced Pluripotent Stem Cells.

One-Step piggyBac Transposon-Based CRISPR/Cas9 Activation of Multiple Genes.

Controlling the Expression Level of the Neuronal Reprogramming Factors for a Successful Reprogramming Outcome

Reprogramming Astrocytes to Motor Neurons by Activation of Endogenous Ngn2 and Isl1

Cell Reprogramming With CRISPR/Cas9 Based Transcriptional Regulation Systems

Direct cell reprogramming: approaches, mechanisms and progress